Current Opinion in Neurology

Papers
(The H4-Index of Current Opinion in Neurology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation85
Management of neuropsychiatric symptoms in dementia54
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis52
Chemotherapy and targeted therapies for meningiomas: what is the evidence?50
The recent surge of functional movement disorders: social distress or greater awareness?47
Update on management of cerebral venous thrombosis43
The role of the gut microbiome in Alzheimer's disease pathophysiology41
Editorial introductions39
Microglia in multiple sclerosis – pathogenesis and imaging36
Historical development and contemporary use of neuromodulation in human spinal cord injury33
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies33
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies29
Hereditary motor neuropathies29
Gene therapies for CMT neuropathies: from the bench to the clinic29
From basic mechanisms to therapeutic perspectives in cluster headache27
Central nervous system adverse events of immune checkpoint inhibitors26
Neurology education in the era of artificial intelligence25
The 2021 WHO classification of central nervous system tumors: what neurologists need to know25
Editorial introductions24
Editorial: Epilepsy advances in 202323
Multiple sclerosis in China: the current state of diagnosis and management23
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection21
Connecting tremors – a circuits perspective21
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial21
0.15565299987793